Establishment of simultaneous treatment model with citrate for preventing nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor, in rats

References

• Ashizawa, N., Shimo, T., Matsumoto, K., Oba, K., Nakazawa, T., Nagata, O. (2006). Strain differences in the responsiveness between Sprague-Dawley and Fischer rats to nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor. Toxicol Appl Pharmacol 217:260–265.
   PubMed Web of Science ®Google Scholar
• Clayson, D. B. (1974). Bladder carcinogenesis in rats and mice: possibility of artifacts. J Natl Cancer Inst 52:1685–1689.
   PubMed Web of Science ®Google Scholar
• Cohen, S. M., Lawson, T. A. (1995). Rodent bladder tumors do not always predict for humans. Cancer Lett 93:9–16.
   PubMed Web of Science ®Google Scholar
• Cohen, S. M. (1999). IARC Scientific Publications, No. 147. Calcium phosphate-containing urinary precipitate in rat urinary bladder carcinogenesis. World Health Organization International Agency for Research on Cancer [online]. Available at: http://monographs.iarc.fr/ENG/Publications/pub147/IARCpub147.pdf. Accessed on February 12, 2010.
   Google Scholar
• Dunning, W. F., Curtis, M. R., Segaloff, A. (1947). Strain differences in response to diethylstilbestrol and the induction of mammary gland and bladder cancer in the rat. Cancer Res 7:511–521.
   Web of Science ®Google Scholar
• Elion, G. B., Callahan, S., Nathan, H., Bieber, S., Rundles, R. W., Hitchings, G. H. (1963). Potentiation by inhibition of drug degradation. Biochem Pharmacol 12:85–93.
   Web of Science ®Google Scholar
• Engelmann, U., Schramek, P., Baum, H. P., Wertmann, B., Grun, M., Jacobi, G. H. (1987). Bladder carcinogenesis in portacaval shunt rats. Urol Int 42:165–169.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. (2008). CHMP Assessment Report for Adenuric (febuxostat). Doc Ref: EMEA/258531 [online]. Available at: http://www.ema.europa.eu/humandocs/PDFs/EPAR/adenuric/H-777-en6.pdf. Accessed on February 12, 2010
   Google Scholar
• Fukushima, S., Thamavit, W., Kurata, Y., Ito, N. (1986). Sodium citrate: a promoter of bladder carcinogenesis. Jpn J Cancer Res 77:1–4.
   PubMedGoogle Scholar
• Fukushima, S., Tanaka, H., Asakawa, E., Kagawa, M., Yamamoto, A., Shirai, T. (1992). Carcinogenicity of uracil, a nongenotoxic chemical, in rats and mice and its rationale. Cancer Res 52:1675–1680.
   PubMed Web of Science ®Google Scholar
• Hasegawa, Y., Matsuzaki, K., Yotsuya, K., Ishikawa, H., Mokuhata, N., Fumino, H., et al. (1986). One-year chronic toxicity study by oral gavage in rats of CG-120 [Japanese]. Kiso Rinsho 20:4547–4577.
   Google Scholar
• Heck, Hd’ A., Wolkowski-Tyl, R. (1985). The induction of bladder stones by terephthalic acid, dimethyl terephthalate, and melamine (2,4,6-triamino-s-triazine) and its relevance to risk assessment. Reg Toxicol Pharmacol 5:294–313.
   PubMed Web of Science ®Google Scholar
• Ogasawara, H., Imaida, K., Ishiwata, H., Toyoda, K., Kawanishi, T., Uneyama, C., et al. (1995). Urinary bladder carcinogenesis induced by melamine in F344 male rats: correlation between carcinogenicity and urolith formation. Carcinogenesis 16:2773–2777.
   PubMed Web of Science ®Google Scholar
• Ogawa, Y., Yamaguchi, K., Tanaka, T., Morozumi, M. (1986). Effects of pyruvate salts, pyruvic acid, and bicarbonate salts in preventing experimental oxalate urolithiasis in rats. J Urol 135:1057–1060.
   PubMed Web of Science ®Google Scholar
• Okamoto, K., Matsumoto, K., Hille, R., Eger, B. T., Pai, E. F., Nishino, T. (2004). The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition. Proc Natl Acad Sci U S A 101:7931–7936.
   PubMed Web of Science ®Google Scholar
• Shimo, T., Ashizawa, N., Matsumoto, K., Nakazawa, T., Nagata, O. (2005). Simultaneous treatment with citrate prevents nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor, in rats. Toxicol Sci 87:267–276.
   PubMed Web of Science ®Google Scholar
• Shimo, T., Ashizawa, N., Moto, M., Matsumoto, K., Iwanaga, T., Nagata, O. (2009). FYX-051, a xanthine oxidoreductase inhibitor, induces nephropathy in rats, but not in monkeys. Toxicol Pathol 37:438–445.
   PubMed Web of Science ®Google Scholar
• Shirai, T., Ikawa, E., Fukushima, S., Masui, T., Ito, N. (1986). Uracil-induced urolithiasis and the development of reversible papillomatosis in the urinary bladder of F344 rats. Cancer Res 46:2062–2067.
   PubMed Web of Science ®Google Scholar
• Toyoda, K., Imaida, K., Shirai, T., Imazawa, T., Takahashi, M. (1993). Relationship between bisacodyl-induced urolithiasis and rat urinary bladder carcinogenesis. J Toxicol Environ Health 39:59–78.
   PubMed Web of Science ®Google Scholar
• Weil, C. S., Carpenter, C. P., Smyth, H. F. (1965). Urinary bladder response to diethylene glycol. Arch Environ Health 11:569–581.
   PubMed Web of Science ®Google Scholar
• West, T. W., Frith, C. H., Stanley, J. W., Jackson, C. D. (1981). The role of urinary physiological changes in the genesis of urothelial lesions in mice given 4, 4-ethylsulfonyl-naphthalene-1-sulfonamide, acetazolamide, and oxatomide. J Environ Pathol 5:575–580.
   Google Scholar